- Home
- NVAX vs ADEA Comparison
NVAX vs ADEA Comparison
Compare NVAX & ADEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- ADEA
- Stock Information
- Founded
- NVAX 1987
- ADEA 1990
- Country
- NVAX United States
- ADEA United States
- Employees
- NVAX N/A
- ADEA N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- ADEA Computer Software: Prepackaged Software
- Sector
- NVAX Health Care
- ADEA Technology
- Exchange
- NVAX Nasdaq
- ADEA Nasdaq
- Market Cap
- NVAX 1.4B
- ADEA 1.5B
- IPO Year
- NVAX 1995
- ADEA N/A
- Fundamental
- Price
- NVAX $7.19
- ADEA $13.91
- Analyst Decision
- NVAX Hold
- ADEA Strong Buy
- Analyst Count
- NVAX 8
- ADEA 4
- Target Price
- NVAX $11.38
- ADEA $19.50
- AVG Volume (30 Days)
- NVAX 4.2M
- ADEA 824.1K
- Earning Date
- NVAX 11-06-2025
- ADEA 11-03-2025
- Dividend Yield
- NVAX N/A
- ADEA 1.43%
- EPS Growth
- NVAX N/A
- ADEA 75.65
- EPS
- NVAX 2.07
- ADEA 0.65
- Revenue
- NVAX $1,064,651,000.00
- ADEA $379,912,000.00
- Revenue This Year
- NVAX $59.49
- ADEA $9.49
- Revenue Next Year
- NVAX N/A
- ADEA $4.94
- P/E Ratio
- NVAX $3.47
- ADEA $21.47
- Revenue Growth
- NVAX 20.27
- ADEA 10.53
- 52 Week Low
- NVAX $5.01
- ADEA $10.59
- 52 Week High
- NVAX $11.55
- ADEA $18.25
- Technical
- Relative Strength Index (RSI)
- NVAX 36.23
- ADEA 36.07
- Support Level
- NVAX $7.08
- ADEA $12.10
- Resistance Level
- NVAX $7.90
- ADEA $14.57
- Average True Range (ATR)
- NVAX 0.37
- ADEA 0.79
- MACD
- NVAX -0.12
- ADEA -0.29
- Stochastic Oscillator
- NVAX 7.17
- ADEA 28.98
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About ADEA Adeia Inc.
Adeia Inc is a consumer and entertainment product/solutions licensing company. Its only operating segment being Intellectual Property (IP) Licensing. In the IP segment, the company licenses innovations to companies in the broader entertainment industry, and those developing new technologies that will help drive this industry forward. It includes Pay-TV, Consumer Electronics, Connected Car, and Media Platform.